ARCHIVES

ODAC Recommends TICE BCG Approval For Recurrent Bladder Cancer Prevention

This article is from The Cancer Letter archive.

Vol. 23 No. 01 | January 10, 1997

Download PDF Visit The Full Archive

Related Articles

HHS Plan Ties Breast Screening; Mammography Quality

July 16, 1993

Tarceva Added To Gemcitabine Improves Pancreatic Cancer Survival, Study Finds

February 25, 2005

Health Organizations: ACS Advises annual Prostate Screening for some Younger Men

June 20, 1997

Rituximab Prolonged Survival Of CLL In Phase III Study

September 24, 2010

Black Women More Likely To Have Aggressive, Less Treatable Breast Cancer

September 28, 2007

FDA, NIH Streamline Approvals For Gene Therapy Studies

June 16, 1995